SCHEMBL28755281

SCHEMBL28755281

O=C(/C=C(\Nc1ccccc1O)c1ccccc1)c1ccc2ccccc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 3/20 0.51
▸ MAPT P10636 4/20 0.47
▸ KDM4E B2RXH2 4/20 0.47
▸ KMT2A Q03164 4/20 0.47
▸ MEN1 O00255 3/20 0.47
▸ ALDH1A1 P00352 2/20 0.47
▸ HPGD P15428 2/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ TP53 P04637 2/20 0.47
▸ EGFR P00533 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ PKM P14618 1/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ ALOX12 P18054 1/20 0.47
▸ JAK1 P23458 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ CYP1B1 Q16678 1/20 0.46
▸ TERT O14746 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28755192 0.86 GAA (0.60) GAAMAPTKDM4EKMT2AMEN1
SCHEMBL28942168 0.82 GAA (0.54) GAAMAPTKDM4EKMT2AMEN1
SCHEMBL28755189 0.81 GAA (0.56) GAAMAPTKDM4EKMT2AMEN1
SCHEMBL28755330 0.81 GAA (0.56) GAAMAPTKDM4EKMT2AMEN1
SCHEMBL28755342 0.81 GAA (0.53) GAAMAPTKDM4EKMT2AMEN1
SCHEMBL28755329 0.81 KMT2A (0.60) GAAMAPTKDM4EKMT2AMEN1
SCHEMBL28755304 0.81 GAA (0.56) GAAMAPTKMT2AMEN1ALDH1A1
SCHEMBL28755308 0.78 GAA (0.53) GAAMAPTKDM4EKMT2AMEN1
SCHEMBL28755238 0.78 GAA (0.50) GAAMAPTKDM4EKMT2AMEN1
SCHEMBL6627530 0.77 NPC1 (0.69) GAAKDM4EKMT2AMEN1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107382899-B Polysubstituted 2-hydroxy-1, 4-benzoxazine derivative 华侨大学 2021-11-30 — — CN disclosed
Send feedback